- Home
- TWST
as 11-22-2024 4:00pm EST
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 2.7B | IPO Year: | 2018 |
| Target Price: | $52.25 | AVG Volume (30 days): | 908.0K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $23.07 - $60.90 | Next Earning Date: | 11-18-2024 |
| Revenue: | $312,974,000 | Revenue Growth: | 27.69% |
| Revenue Growth (this year): | 21.05% | Revenue Growth (next year): | 20.16% |
Stock Insider Trading Activity of Twist Bioscience Corporation (TWST)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Leproust Emily M. | TWST | Chief Executive Officer | Nov 11 '24 | Sell | $48.00 | 7,968 | $382,448.06 | 581,584 | |
| Green Paula | TWST | SVP of Human Resources | Nov 11 '24 | Sell | $48.00 | 1,347 | $64,653.31 | 114,147 | |
| Cho Dennis | TWST | See Remarks | Nov 11 '24 | Sell | $48.00 | 1,507 | $72,332.99 | 91,163 | |
| Finn Patrick John | TWST | President and COO | Nov 11 '24 | Sell | $48.00 | 10,340 | $496,299.32 | 221,061 | |
| Leproust Emily M. | TWST | Chief Executive Officer | Nov 6 '24 | Sell | $44.61 | 14,334 | $639,368.07 | 581,584 | |
| Green Paula | TWST | SVP of Human Resources | Nov 6 '24 | Sell | $44.61 | 11,038 | $492,349.99 | 114,147 | |
| Cho Dennis | TWST | See Remarks | Nov 6 '24 | Sell | $44.61 | 3,622 | $161,559.31 | 91,163 | |
| WERNER ROBERT F. | TWST | Chief Accounting Officer | Nov 6 '24 | Sell | $44.61 | 2,896 | $129,176.08 | 45,620 | |
| Finn Patrick John | TWST | President and COO | Nov 6 '24 | Sell | $44.61 | 12,478 | $556,581.19 | 221,061 | |
| Laponis Adam | TWST | Chief Financial Officer | Nov 6 '24 | Sell | $44.61 | 4,160 | $185,556.80 | 89,237 |
Latest Twist Bioscience Corporation News
TWST Breaking Stock News: Dive into TWST Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations
TipRanks
4 days ago
Twist Bioscience price target lowered to $52 from $55 at Barclays
Insider Monkey
4 days ago
Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now
Zacks
5 days ago
Company News for Nov 19, 2024
Thomson Reuters StreetEvents
5 days ago
Q4 2024 Twist Bioscience Corp Earnings Call
GuruFocus.com
5 days ago
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
Benzinga
5 days ago
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps
MT Newswires
5 days ago
Update: Twist Bioscience Fiscal Q4 Loss Narrows, Revenue Rises
Compare TWST vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TWST Twist Bioscience Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.